Bone marrow transplant is a procedure now available for dogs suffering from lymphoma. Bone marrow transplant procedures were originally optimized in laboratory dogs; only recently has it been offered as a clinical treatment option. Cost, toxicity risk, limited availability, and lack of published studies showing an outcome advantage in canine patients make this treatment still experimental and not for every patient and owner.
Bone marrow transplantation, in conjunction with chemotherapy, has significantly improved survival and outcome in human cancer patients. Our hope in the veterinary community is that the cure rate in canine patients can be improved to 40% or greater. Hopefully in 1 to 2 years, we will have more data to show whether this is the case.
Canine bone marrow transplants are currently offered at North Carolina State University. If we have an interested client, we work with Dr. Suter from NC State to make sure the procedure goes as smoothly as possible. For more information, please make an appointment to speak with us.
So what is a bone marrow transplant? A bone marrow transplant delivers healthy bone marrow stem cells into the patient. It replaces bone marrow that is either not working properly or has been destroyed (ablated) by chemotherapy or radiation.
Bone marrow is a soft, fatty substance in the middle of bones. Stem cells are immature cells in the bone marrow that can grow and differentiate into red blood cells, white blood cells, or platelets. With bone marrow transplant, you receive healthy stems cells to repopulate your bone marrow after it has been destroyed by medication or radiation.
Prior to transplant, high dose chemotherapy and/or radiation is used to kill cancer cells. After this, the bone marrow transplant occurs to allow blood cell lines to again grow.
It is important to note that bone marrow transplant is risky. Systemic infection, internal bleeding, diarrhea, nausea, vomiting, pain, damage to other organs, cataracts, and death are possible risks. Patients need to stay in the hospital and be closely monitored and treated. Blood transfusions are sometimes needed. Possible results include complete cure, prolonged remission of disease, or death.
It is important to first know that cancer is a broad term for a large group of related diseases, each one having its own expected outcome, course, and treatment. The body is made of different cell types that normally grow, divide, and die in an orderly fashion to keep the body’s systems running smoothly (homeostasis). The body has a “check and balance” system to keep the processes orderly. However, sometimes this system breaks down. Cells form when the body doesn’t need them. Cells spread and invade tissues where they don’t belong. The systems that usually signal to have such cells die remain unheeded. This result is a growth of tissue that may be benign (not cancerous) or malignant.
What causes cancer?
The body has a “check and balance” system that regulates the growth and death of cells. This system is highly complex and involves multiple factors that can signal cells to grow or die. The body has a genetic code that ultimately controls everything. Sometimes, the genetic code is mutated in a fashion that affects these systems. Sometimes tumor suppressor genes become dysfunctional. Sometimes the molecules that bind to these genes and alter their behavior like “on” or “off” switches are disarrayed, leading to unchecked cell growth.
These processes can be disordered from birth, meaning genetics can play a role. Certain breeds are predisposed to certain tumor types. Dogs are more inbred than humans, and this element is likely quite strong. A common sire for many dogs may have carried a genetic mutation that, combined with additional factor, allowed his offspring to be more likely to develop cancer.
These processes can also be affected by environmental factors. Studies have shown that diet, exposure to cigarette smoke, exercise, exposure to sunlight (UV radiation), and exposure to carcinogens (such as pesticides or asbestos) can damage the genes that protect us from unregulated cell growth and promote the development of cancer. Even viruses, like feline leukemia virus, can increase the risk of cancer. Most likely, in each case there is a combination of factors.
Can cancer be prevented?
Yes and no. As a rule, cancer does what it wants. You can do everything right and still have your pet diagnosed with cancer. However, you can reduce the risk of cancer by:
Clinical trials are research studies. They test hypotheses about new treatments for a specific disease. They are designed to answer scientific questions and, hopefully, find better ways to treat patients. Participating in a clinical trial allows you and your pet to contribute to the advancement of treatment for cancer patients. The hope is that the novel treatment may benefit your pet. However, there are no guarantees.
There are several types of clinical trials:
Prevention trials test new approaches. Prevention trials are rare in veterinary medicine but evaluate the use of supplements or medicines that may lower cancer risk. These are larger trials run over longer periods of time that start with healthy pets.
Diagnostic or Screening trials are designed to evaluate diagnostics to determine better ways to detect and monitor cancer. These often provide no immediate benefit to a patient but have large potential to positively affect treatment outcome of other patients in the future.
Genetics trials are often breed-specific and used to study a tumor type in a particular breed. Treatment trials involve patients diagnosed with cancer and are designed to specifically answer questions about a new treatment or new method of treatment.
How are patients protected?
Research is conducted according to strict scientific and ethical principles. Clinical trials should have a written protocol that serves as a unifying plan of action. This describes expected diagnostics and treatments, expected benefits and risks. This protocol is like a recipe that should be followed by every participating patient and veterinarian.
To participate, a client must have an eligible patient as specified in the study protocol. The client must be able to read and understand the client consent form and be aware of the potential benefits and risks of the study. Informed consent is crucial.
How are trials conducted?
Clinical trials are usually conducted in a series of steps, called phases.
Phase I studies are the first step. These are usually “dose finding” studies. The starting dose is usually lower than that expected to be toxic and, potentially, effective. The dose is then escalated as the study progresses to determine the maximum tolerated dose. Sometimes the starting dose is too high and de-escalation occurs.
Phase II trials study the effectiveness and safety of a treatment on a particular cancer.
Phase III trials are larger studies to compare a new treatment to the current standard treatment. Participants are randomly assigned to one arm of the study or the other. Phase III trials usually only start after phase I and II testing show promise for a particular medication and only after a standard starting does is known.
Phase IV trials are rarer but are used to conduct long-term safety evaluation and additionally confirm the effectiveness of a treatment.
What are some of the benefits of taking part in a clinical trial?
What are some of the possible risks associated with taking part in a clinical trial?
What are some questions you should ask?
Where can people find more information about clinical trials?
The best source is a good veterinary oncologist who is up to date on the latest clinical trials. At CARES, we Keep a list of trials that may be of benefit to our patients and can explain the benefits and risks. Essentially, if you are our patient, we want you to be aware of the benefits and risks so that you can make the best decisions for your pets, just as we would do for our own.
Copyright © 2009 CARES
